Progressive GaitWays

AOPA ATTENDEES

UPDATE: AOPAversity now has the Las Vegas presentation available online -- listen in at your convenience.

Otherwise, you can download Beverly Cusick's presentation materials...

PowerPoint slides handout - Cusick presentation (PDF)

...and References (Compressed ZIP format):

...or send an email request with your mailing information, and we'll send you a CD!

Improve Your Skills

Improve Your Understanding

Improve Your Outcomes

Download Flyer Order Online

NOW AVAILABLE!
Serial Casting (2010)... Details 24 Myths, New Understandings, New Concepts & Strategies in the Management of Equinus Deformity

This comprehensive text challenges the scientific and clinical rationale for 24 common assumptions (myths) in equinus deformity management. For example:

Myth #21: Botulinum Toxin-A (BTX-A) and
similar chemicals are safe and
effective in managing equinus deformity.

They are not. More than 100 American children with CP have died of toxic reaction to this poison. Many others have been rendered extremely ill and weak for several months by surviving a toxic reaction.

The US Food and Drug Administration has never authorized the use of BTX-A for equinus deformity in children or adults with presumed spasticity. Any such use is considered "off-label" by the FDA, and cannot be marketed.

The New York Times reports that the FDA has accepted a $600M settlement from Allergan for off-label marketing of Botox. The FDA also recently demanded that warnings be added to Botox packaging. Here's a link to the only FDA-authorized use of Botox for spasticity -- limited to applications to elbow/wrist/finger flexors.

In typical Cusick fashion, this text thoroughly examines the issues and problems associated with ankle equinus deformity development and management, and offers practical orthotic strategies that focus on sensory input and postural control.

Check out the intro on

Beverly Cusick has condensed 20 years of literature review and professional practice to fill a common gap in professional training for allied health professionals, orthopedists, and physical medicine physicians. This 2-hour lecture lays the educational foundation for patient care that involves foot function.

Progressive GaitWays is now
the official supplier of the
TheraTogs Research Partner Program.
For more details...

2011 Courses Now Available

See the Courses home page for more information on these and other upcoming courses:

Want to stay informed on courses, products, and events?

for the PaceSetter, our email newsletter.

What's New at the GaitWays Store...

Helfet Heel Seats are now available in pediatric sizes. Billi uses these prefabricated inserts routinely in her pediatric practice. These inserts are imported from England, and are hard for therapists to find in the US!

Want to Sponsor a Course?

If you would like to consider sponsoring a course, please download the Course Description Summary (PDF) of available courses, or contact us at courses@gaitways.com for more information.

Progressive GaitWays, LLC

NOW AVAILABLE! Serial Casting (2010)... Details 24 Myths, New Understandings, New Concepts & Strategies in the Management of Equinus Deformity

Myth #21: Botulinum Toxin-A (BTX-A) and similar chemicals are safe and effective in managing equinus deformity.

2011 Courses Now Available

What's New at the GaitWays Store...

Want to Sponsor a Course?

NOW AVAILABLE!
Serial Casting (2010)... Details 24 Myths, New Understandings, New Concepts & Strategies in the Management of Equinus Deformity

Myth #21: Botulinum Toxin-A (BTX-A) and
similar chemicals are safe and
effective in managing equinus deformity.